MedPath

A weekly dose comparison of 5000 units of vitamin D supplementation with a daily dose of 4,000 units in patients with chronic leukemia

Phase 2
Conditions
Chronic lymphocytic leukemia.
Other lymphoid leukaemia
Registration Number
IRCT20180912041010N1
Lead Sponsor
Qazvin University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
20
Inclusion Criteria

Chronic lymphocyte leukemia with a serum level of vitamin D of less than 30

Exclusion Criteria

Hepatic failure
Renal failure
Get Vitamin D supplementation in the last three months

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patient tolerance to the dose. Timepoint: 6 months after intervention. Method of measurement: Vitamin D Serum level in the blood sample.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath